| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |